Leading Pharmaceutical Innovation
Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Reviews / Votes
From the reviews:
"This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies . . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies . . The six-page glossary of industry terms, when used with its decent index, is a particular joy. . recommend this offering to prospective managers and researchers in this industry . ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)
More details
Other editions
New editions
Additional editions
